Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy. - Wikidata - wikimedia - TriplyDB

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

http://www.wikidata.org/entity/Q42182888

about

Concepts and mechanisms underlying chemotherapy induced immunogenic cell death: impact on clinical studies and considerations for combined therapies Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances Trial Watch: Immunogenic cell death inducers for anticancer chemotherapy The STING pathway and the T cell-inflamed tumor microenvironment Trial Watch-Oncolytic viruses and cancer therapy EZH2 as a mediator of treatment resistance in melanoma PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor Efficacy Trial Watch-Immunostimulation with cytokines in cancer therapy Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer The interplay of immunotherapy and chemotherapy: harnessing potential synergies Immunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translation Integration of genomic, transcriptomic and proteomic data identifies two biologically distinct subtypes of invasive lobular breast cancer.Expression of Myxovirus Resistance A (MxA) Is Associated with Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancers.Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs in hematological malignancies.IAP antagonists induce anti-tumor immunity in multiple myeloma.DNA-damage-induced type I interferon promotes senescence and inhibits stem cell function.Molecular analyses of juvenile granulosa cell tumors bearing AKT1 mutations provide insights into tumor biology and therapeutic leads.The Hippo Pathway Kinases LATS1/2 Suppress Cancer Immunity Classification of current anticancer immunotherapies A distinct pre-existing inflammatory tumour microenvironment is associated with chemotherapy resistance in high-grade serous epithelial ovarian cancer.Combinatorial strategies for the induction of immunogenic cell death.Porous silicon microparticle potentiates anti-tumor immunity by enhancing cross-presentation and inducing type I interferon response.Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses Autocrine signaling of type 1 interferons in successful anticancer chemotherapy Structural analysis of tumor-related single amino acid mutations in human MxA protein TLR3-Induced Maturation of Murine Dendritic Cells Regulates CTL Responses by Modulating PD-L1 Trafficking.IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death.Superoxide Dismutase 1 Protects Hepatocytes from Type I Interferon-Driven Oxidative Damage Doxil synergizes with cancer immunotherapies to enhance antitumor responses in syngeneic mouse models.Cancer immunotherapy: Strategies for personalization and combinatorial approaches.STING-cytosolic DNA sensing: the backbone for an effective tumor radiation therapy.Computational pathology of pre-treatment biopsies identifies lymphocyte density as a predictor of response to neoadjuvant chemotherapy in breast cancer.RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors Differences in the composition of the immune infiltrate in breast cancer, colorectal carcinoma, melanoma and non-small cell lung cancer: A microarray-based meta-analysis.Improvement of immunogenic chemotherapy by STAT3 inhibition.Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer The oncolytic peptide LTX-315 triggers immunogenic cell death.

P2860

Q26781215-436F10D8-02CF-49D3-AA98-691CCB424B3A Q26795466-BB7CB212-6F4E-4DEB-812D-8CA9F1849371 Q26863779-BDCF2913-0B56-42E7-BFAF-39E6DE988052 Q27004011-2142C76E-7191-441A-9ACA-F48F55DFC315 Q27008371-862F2742-F656-4597-A4D8-750A73A41EA5 Q28072347-8367D5F3-060C-45BF-A8B4-B115404D1AFC Q28074492-71FE59CF-4ADF-4E1B-BE5D-6198B9122DF2 Q28075712-CBAC1D4D-8E91-4ED9-AFD8-462F89063391 Q28076473-231D34A2-21E9-48A5-B946-E0AAB58F8EA4 Q28078725-26326886-DC26-488A-A464-7397F640638F Q28080773-73E674CF-7336-4AF8-9CEC-C73891201BC1 Q28081893-421C9656-E55F-4CEE-AD4F-2C93196BC4D9 Q28386858-BA2C9D9C-C214-42F2-A95A-66B7B7ED578C Q31034941-A9179215-A73D-44CD-B8C5-68E381BDC333 Q33584106-A9D0B240-88CB-48F2-991B-6AEA0373C2E0 Q33762936-D6A4CC32-807F-4590-BA45-3214CC1BC69C Q33914862-815B20C5-CDFC-4B8C-AD95-49F9CF98872F Q34474083-67ABC40B-7768-4814-8446-85961B346135 Q34493715-E144B57D-A064-4B97-85F6-FB2DFFFD96A6 Q34546530-759A78C2-84E0-4D76-BBEC-6C521B92D2E9 Q35149637-3352223C-0C73-43D5-A9D8-FDC682CD7328 Q35274995-136C411C-693B-4E48-8DC4-930C13EE5384 Q35535140-ED64125F-E680-43D8-A09C-846BA1ABEC6C Q35607012-D48BD972-7DDA-4DA5-AAB2-3FD145E0DD13 Q36015063-EC67941D-6218-4D24-9A70-2298EE1994F1 Q36060217-41228AB2-2A82-48A1-9AFD-DADAF46B93CA Q36121243-D9D82E80-D999-47F4-892A-E8B28502148B Q36212034-FD45B694-54A3-4C2F-8A03-BEBB979F1EE3 Q36266768-8A8C012F-1E96-49C3-81AD-1B21C33EADBD Q36301061-EE5F8FF5-1D26-4A39-9FDF-8857588D7542 Q36315988-900C86B7-A83A-4F48-BE43-49244501FB1D Q36360125-410186BF-3999-417A-8863-DBB3BD382146 Q36387028-30A6DB19-722E-4B63-AD74-C292DBC027F2 Q36540171-E2BAC3BE-7FA3-460A-9565-ED7D3B7935D4 Q36584124-D6144596-1D35-4012-9104-07654A5CE659 Q36693087-4E29C8B3-2540-4A93-919A-3D4762028AC1 Q36710922-3A945E1F-4337-4676-A1A3-1580243DF622 Q36710966-B727DE6F-03FB-44B6-AC13-0A1F1F944899 Q36750699-6DC1DCAD-6C9E-440E-B1AC-480799816270 Q36774984-A0E2C081-3CF0-4EB6-833D-ECDDD7FA71F4

P2860

Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy.

http://www.wikidata.org/entity/Q42182888

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Cancer cell-autonomous contrib ...... the efficacy of chemotherapy.

@en

Cancer cell-autonomous contrib ...... the efficacy of chemotherapy.

@nl

type

label

Cancer cell-autonomous contrib ...... the efficacy of chemotherapy.

@en

Cancer cell-autonomous contrib ...... the efficacy of chemotherapy.

@nl

prefLabel

Cancer cell-autonomous contrib ...... the efficacy of chemotherapy.

@en

Cancer cell-autonomous contrib ...... the efficacy of chemotherapy.

@nl

P1433

Q42182888-8B6A8AA3-6D24-41FD-AEDF-E8572784CE9B

P1476

Q42182888-DE9EFEC8-A0E1-453F-BC08-5BE61C2D319E

P2093

Q42182888-02B90A45-B439-45A8-A2BF-BE7908888A6D

Q42182888-0C996A0D-5CE8-4833-9B1A-170A4A7DEBF1

Q42182888-1EAC1A85-E856-450E-86B4-366A3EBA84C9

Q42182888-20134000-7C6D-43A9-95E8-1ABA3A0E39A7

Q42182888-20FAEA63-55DC-4DEB-A9CC-EC580BBD5B15

Q42182888-2332452F-7B61-414F-AB3E-ECD3838F595D

Q42182888-276C75C5-03BA-4EF1-A0ED-32D60FA3EE86

Q42182888-28F19A68-B451-4BCE-A9FE-1350EEFEE468

Q42182888-394BC0FE-B2E6-4EF4-9693-62D4F152845F

Q42182888-45EA59F2-C241-41CC-9B65-B641C7119C0D

P2860

Q42182888-01F96088-AACA-42C3-9097-333A8EAB9C05

Q42182888-02E83CEF-F0C2-424D-B027-3E819053822D

Q42182888-038C5115-CF46-464C-B499-E702C22AD2E2

Q42182888-0A345545-9BA0-487B-88A9-82520140681E

Q42182888-0DE059F4-B133-4C6B-A8A5-FD90486F79F0

Q42182888-10FF15C6-A84E-4750-B98A-D16EE712EB78

Q42182888-15F8C35F-4609-4A21-9F97-3EFDB715E4EF

Q42182888-17DF5A47-7720-428B-AC7B-E422540360E6

Q42182888-1D0223C7-81C8-4D67-97CA-0B56A200B439

Q42182888-1E0BE948-9525-4D9F-A4A2-1F8E125F695C

P2888

Q42182888-FCF11D80-F88E-4B94-84D7-86DE44E7785B

P304

Q42182888-5984B148-5236-4F03-99A9-DCAD721406D7

P31

Q42182888-0F884F33-3AFA-406D-9081-53325537CAEF

P356

Q42182888-5D203ABB-D12D-4B82-9993-A0A5B7CC3041

P407

Q42182888-410291F2-C585-4491-B181-7A60B8190A94

P433

Q42182888-3858E9AB-54AB-460D-9D7C-85E5721654EC

P478

Q42182888-16A1AD73-B70B-4D95-973D-C6BF16D983A6

P50

Q42182888-05B4AE39-AA14-46B7-9A5C-BE014FA6A295

Q42182888-1D916675-F677-4826-8FBC-E88255497A03

Q42182888-28CB9A40-D549-4DFE-9D45-ED1D6924CFA9

Q42182888-390B84DD-1FBF-4983-A424-16BF1112B11E

Q42182888-5185D234-EB63-4143-8596-4E9A9F4343AC

Q42182888-5884AA8E-6AF1-43FA-A67D-57E438E1FE52

Q42182888-5C475C9A-EC1E-4E14-A3E1-4BEA76E72825

Q42182888-5DAA2AEA-3F15-4225-9BB2-DB8DEABFF562

Q42182888-66F0CF14-AAF9-4A99-B38C-1A629FD08502

Q42182888-6C45036A-73F0-45B0-9AED-80A67F890B61

P577

Q42182888-BB258D79-D042-4572-9D3F-2882F56E6B15

P5875

Q42182888-26A70769-A842-4924-AB79-5692259CA211

P698

Q42182888-DE8673E4-3A0A-4A73-986E-79ECB048D04A

P921

Q42182888-10558E47-8DAA-418F-ABBC-8B2D6DB8EF3C

P356

P1433

Nature Medicine

P1476

Cancer cell-autonomous contrib ...... the efficacy of chemotherapy.

@en

P2093

Aicha Goubar

http://www.w3.org/2001/XMLSchema#string

Alexander Eggermont

http://www.w3.org/2001/XMLSchema#string

Camilla Engblom

http://www.w3.org/2001/XMLSchema#string

Christina Pfirschke

http://www.w3.org/2001/XMLSchema#string

David P Enot

http://www.w3.org/2001/XMLSchema#string

Elisa E Baracco

http://www.w3.org/2001/XMLSchema#string

Fabrice André

http://www.w3.org/2001/XMLSchema#string

Francesca Urbani

http://www.w3.org/2001/XMLSchema#string

Frederique Penault-Llorca

http://www.w3.org/2001/XMLSchema#string

Gilles Uzè

http://www.w3.org/2001/XMLSchema#string

P2860

The unfolded protein response: integrating stress signals through the stress sensor IRE1α

Autophagy in immunity and inflammation

Cytosolic sensing of viruses

PAMPs and DAMPs: signal 0s that spur autophagy and immunity

Interferon-inducible CXC chemokines directly contribute to host defense against inhalational anthrax in a murine model of infection.

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

The danger model: a renewed sense of self

P2888

P304

1301-1309

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.3708

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P50

Laurence Zitvogel

Alexander Eggermont

Mireia Niso-Santano

Frédérique Penault-Llorca

Antonella Sistigu

Vichnou Poirier-Colame

P577

2014-10-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267568644

http://www.w3.org/2001/XMLSchema#string

P698

25344738

http://www.w3.org/2001/XMLSchema#string

P921